Elevance Health Inc.

NYSE:ELV

541.91 (USD) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 171,340156,595138,639121,867104,21392,10590,039.484,86379,156.573,874.171,023.561,711.760,710.758,801.865,028.161,251.161,134.356,95345,13620,815.116,771.413,282.310,444.717,314.512,350.711,072.1
Cost of Revenue 17,29313,03510,8958,9531,992000000000000000000000
Gross Profit 154,047143,560127,744112,914102,22192,10590,039.484,86379,156.573,874.171,023.561,711.760,710.758,801.865,028.161,251.161,134.356,95345,13620,815.116,771.413,282.310,444.717,314.512,350.711,072.1
Gross Profit Ratio 0.8990.9170.9210.9270.981111111111111111111111
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 00000011,254.111,166.411,093.710,258.38,4267,151.46,818.87,229.17,973.67,242.16,984.77,163.25,798.52,940.53,109.62,506.61,986.1000
Selling & Marketing Expenses 0000001,395.51,391.51,441.11,490.11,526.91,586.91,616.81,610.31,685.51,778.41,716.81,654.51,474.2537.2000000
SG&A 36,45017,68615,91417,45013,36414,02012,649.612,557.912,534.811,748.49,952.98,738.38,435.68,839.49,659.19,020.58,701.58,817.77,272.73,477.73,109.62,506.61,986.1000
Other Expenses 38,265-31,449-27,048-26,111-15,694-14,373-12,818-12,724.9000000000000000000
Operating Expenses 38,26517,68615,914-126,013-98,228-86,28412,649.612,557.912,534.811,748.49,952.98,738.38,435.68,839.49,659.19,020.58,701.58,817.77,272.73,477.71,180.7962.2-9,858.9-17,088.5-12,305.8-10,899.7
Operating Income -47,7697,9256,2385,9855,0683,963.84,555.44,6314,368.13,840.23,865.53,957.94,353.87,4033,122.45,257.94,914.43,890.31,443.31,219.1807.6524.617,314.512,350.711,072.1
Operating Income Ratio -00.050.0570.0510.0570.0550.0440.0540.0590.0590.0540.0630.0650.0740.1140.0510.0860.0860.0860.0690.0730.0610.05111
Total Other Income Expenses Net 7,715-85112,64810,384-82,872-75333.135.143.141.340.4297.73,895.63,830.87,788.74,478.25,269.34,981.13,919.32,043.51,601.21,341.31,199.9000
Income Before Tax 7,7157,7697,9256,2385,9855,0683,963.84,555.44,6314,368.13,840.23,865.53,957.94,353.87,4033,122.45,257.94,914.43,890.31,443.31,219.1807.6524.6000
Income Before Tax Ratio 0.0450.050.0570.0510.0570.0550.0440.0540.0590.0590.0540.0630.0650.0740.1140.0510.0860.0860.0860.0690.0730.0610.05000
Income Tax Expense 1,7241,7501,8301,6661,1781,3181212,085.62,0711,8081,205.91,2101,311.21,466.72,657.1631.71,912.51,819.51,426.5483.2440.1255.2183.4-226-44.9-172.4
Net Income 5,9875,8946,1584,5724,8073,7503,842.82,469.82,5602,569.72,489.72,655.52,646.72,887.14,745.92,490.73,345.43,094.92,463.8960.1774.3549.1342.222644.9172.4
Net Income Ratio 0.0350.0380.0440.0380.0460.0410.0430.0290.0320.0350.0350.0430.0440.0490.0730.0410.0550.0540.0550.0460.0460.0410.0330.0130.0040.016
EPS 25.3824.5625.0418.2318.8114.7515.019.369.89.588.498.717.87.6410.5555.644.934.033.152.82.311.661.10.220.84
EPS Diluted 25.2224.2824.7317.9818.4714.7514.359.219.388.998.28.187.256.949.884.765.564.823.943.052.732.261.651.10.220.84
EBITDA 1,7419,4449,2277,3927,1186,1954,854.25,467.25,538.95,219.14,7494,606.24,595.14,456.97,510.13,227.85,844.15,519.34,524.11,722.41,464.1964.6645.117,314.512,350.711,072.1
EBITDA Ratio 0.010.060.0670.0610.0680.0670.0540.0640.070.0710.0670.0750.0760.0760.1150.0530.0960.0970.10.0830.0870.0730.062111